PMID- 14734734 OWN - NLM STAT- MEDLINE DCOM- 20040507 LR - 20190516 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 172 IP - 3 DP - 2004 Feb 1 TI - Autoreactive B cells in lupus-prone New Zealand black mice exhibit aberrant survival and proliferation in the presence of self-antigen in vivo. PG - 1553-60 AB - To identify defects in B cell tolerance that may contribute to the production of autoantibodies in New Zealand Black (NZB) mice, we crossed soluble hen egg white lysozyme (sHEL) and anti-HEL Ig transgenes (Ig Tg) onto the NZB background. In this study, we have examined one of the first checkpoints involved in maintenance of peripheral B cell tolerance, follicular exclusion and elimination of self-reactive B cells in the absence of T cell help. Freshly isolated anti-HEL Ig Tg B cells were labeled with CFSE, adoptively transferred into sHEL recipients, and the fate of self-reactive anti-HEL Ig Tg B cells was followed using flow cytometry and immunofluorescence microscopy. Although anti-HEL Ig Tg B cells from NZB mice are appropriately excluded from B cell follicles in NZB sHEL recipient mice, they demonstrate aberrant survival, proliferation, and generation of anti-HEL Ab-producing cells. This abnormal response results from an intrinsic defect in NZB B cells, requires the presence of CD4(+) T cells, and is facilitated by the splenic environment in NZB mice. Thus, NZB mice have immune defects that interact synergistically to allow autoreactive B cells to become activated despite the presence of tolerizing autoantigens. FAU - Chang, Nan-Hua AU - Chang NH AD - Arthritis Centre of Excellence, Toronto Western Research Institute, Toronto, Ontario, Canada. FAU - MacLeod, Ralph AU - MacLeod R FAU - Wither, Joan E AU - Wither JE LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Autoantibodies) RN - 0 (Immunoglobulin Heavy Chains) RN - EC 3.2.1.- (hen egg lysozyme) RN - EC 3.2.1.17 (Muramidase) SB - IM MH - Adoptive Transfer MH - Animals MH - Autoantibodies/*biosynthesis MH - B-Lymphocyte Subsets/*immunology/*metabolism/pathology/transplantation MH - CD4-Positive T-Lymphocytes/immunology MH - Cell Differentiation/genetics/immunology MH - Cell Division/genetics/immunology MH - Cell Survival/genetics/immunology MH - Chickens MH - Crosses, Genetic MH - Immunoglobulin Heavy Chains/genetics/immunology MH - Interphase/genetics/immunology MH - Lupus Erythematosus, Systemic/genetics/*immunology/pathology MH - Lymphocyte Activation/genetics MH - Major Histocompatibility Complex/genetics/immunology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Inbred NZB MH - Mice, Transgenic MH - Muramidase/genetics/immunology MH - Self Tolerance/genetics/*immunology MH - Transgenes/immunology EDAT- 2004/01/22 05:00 MHDA- 2004/05/08 05:00 CRDT- 2004/01/22 05:00 PHST- 2004/01/22 05:00 [pubmed] PHST- 2004/05/08 05:00 [medline] PHST- 2004/01/22 05:00 [entrez] AID - 10.4049/jimmunol.172.3.1553 [doi] PST - ppublish SO - J Immunol. 2004 Feb 1;172(3):1553-60. doi: 10.4049/jimmunol.172.3.1553.